The Erosion of the Safe Harbor: Strategic Adaptation in the Era of “Label-Plus” Liability and Regulatory Rigor
In the relentless evolution of the pharmaceutical landscape, one thing is clear: the traditional "safe harbor" strategies that once shielded companies from legal and regulatory pitfalls are rapidly eroding. This shift isn’t just a minor regul…
